We are currently developing the platform for North American distribution around our rights to use Lexaria Bioscience Corp.’s ground-breaking DehydraTECH patent portfolio for product development, licensing and B2B sales of cannabis ingredients.

Source: https://thegrizzlygazette.com/media-release/hill-street-provides-update-letter-from-the-ceo-to-shareholders-and-opens-registration-for-a-corporate-update-presentation-to-be-held-on-may-2-2023/